Targeted drug delivery using biodegradable implants
Official title: Controlled focal drug delivery by endovascular bioresorbable composite implants
Funded at University of California Riverside · NIH-11092191 · Data updated 2026-11-12
This study is looking at new implants that can deliver medicine right to places like tumors or inflamed areas in your body, helping to treat conditions more effectively while causing fewer side effects.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | June 1, 2024 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $78,750 |
| NIH project number | 5R03EB035750-02 |
| Project ID | NIH-11092191 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals with localized conditions such as tumors, inflammatory bowel disease, or focal epilepsy.
✕Less likely to help
Patients with systemic diseases or those who do not have focal disease processes may not benefit from this research.
What this research studies
This research focuses on developing innovative implants that can deliver drugs directly to specific areas of the body, such as tumors or inflamed tissues, while minimizing side effects. By using bioresorbable composite materials, these implants can release medication precisely where it's needed and then safely dissolve in the body. This approach aims to reduce the harmful effects associated with traditional drug delivery methods, which often affect other organs. Patients may benefit from more effective treatments with fewer adverse reactions.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for various focal diseases.
How similar studies have gone: Previous research has shown promise in targeted drug delivery technologies, but this specific approach using bioresorbable implants is relatively novel.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Zagha, Edward W — University of California Riverside
- Study coordinator: Zagha, Edward W
Related research
Other NIH-funded projects on the same topics.
-
Cellular programming by plant signaling in cancer and other diseases
Scientists are studying how plant cell signals control gene activity in the nucleus and mitochondria to understand faulty regulation that can occur in cancers and other disorders.
-
Caveolin-1 helps brain vessels stay healthy after juvenile concussion
A study in kids and young adults looks at how a protein called Caveolin-1 affects brain blood vessels after a mild concussion and whether targeting it could protect long-term brain health.
-
How tiny cell antennae control signals linked to birth defects and cancer
Researchers are looking for new proteins in cells' tiny antennae that control signals involved in certain birth defects and cancers to point toward future treatments.
-
New ways to make natural compounds that could fight cancer, Alzheimer's, and inflammation
A scientist team will make and test natural-looking molecules to see if they can block proteins linked to cancer, Alzheimer's disease, and inflammatory conditions.
-
Promoting Coping Skills to Reduce Health Gaps in Teens and Young Adults
A study tests a shift-and-persist coping approach to help racial/ethnic minority teens and young adults handle stress and reduce risks for chronic disease.
-
Laser particle barcoding to track live cells and their omics in breast cancer
A new technique uses special laser-coded particles to follow individual breast cancer cells in real time while linking their live behavior to multi-omics data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.